Julian Baker’s Zymeworks ZYME Stock Holding History

Julian Baker’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,708,472	Closed	-$13.4M	–	112
2022 Q4	$13.4M	Hold	1,708,472	–	–	0.08%	52
2022 Q3	$10.5M	Hold	1,708,472	–	–	0.07%	63
2022 Q2	$9.05M	Hold	1,708,472	–	–	0.05%	63
2022 Q1	$11.2M	Hold	1,708,472	–	–	0.06%	63
2021 Q4	$28M	Hold	1,708,472	–	–	0.14%	49
2021 Q3	$49.6M	Hold	1,708,472	–	–	0.22%	37
2021 Q2	$59.3M	Hold	1,708,472	–	–	0.26%	35
2021 Q1	$54M	Hold	1,708,472	–	–	0.23%	37
2020 Q4	$80.7M	Hold	1,708,472	–	–	0.3%	23
2020 Q3	$79.6M	Hold	1,708,472	–	–	0.32%	21
2020 Q2	$61.6M	Hold	1,708,472	–	–	0.27%	30
2020 Q1	$60.6M	Hold	1,708,472	–	–	0.37%	22
2019 Q4	$77.7M	Hold	1,708,472	–	–	0.41%	23
2019 Q3	$42.4M	Hold	1,708,472	–	–	0.29%	28
2019 Q2	$37.6M	Hold	1,708,472	–	–	0.26%	37
2019 Q1	$27.6M	Hold	1,708,472	–	–	0.18%	35
2018 Q4	$25.1M	Buy	1,708,472 +397,387	+30%	+$5.21M	0.21%	30
2018 Q3	$20.6M	Hold	1,311,085	–	–	0.14%	42
2018 Q2	$19.4M	Buy	+1,311,085	New	+$20.3M	0.15%	42

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Julian Baker's ZYME Position: Q1 2023 in Review

Julian Baker sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 1,708,472 shares — an estimated $13.4M sold.

Julian Baker first reported a position in ZYME in Q2 2018 and held it in 19 quarters. The position peaked at $80.7M in Q4 2020. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

Julian Baker reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
Julian Baker sold 1,708,472 Zymeworks shares in Q1 2023, an estimated $13.4M.
Julian Baker first reported a position in Zymeworks in Q2 2018 and held it in 19 quarters.
Julian Baker's Zymeworks position peaked at $80.7M in Q4 2020.
115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Baker Bros. Advisors's 13F filing for Q1 2023, filed 15 May 2023.